Answers are grounded in this paper and cite their sources.
Genetic disruption of immunoglobulin loci has long established the requirement for heavy- and light-chain rearrangement during B-cell development. Here, we generated Igh -KO, Igκ -KO, and Igh/Igκ double-KO mice by CRISPR/Cas9-mediated deletion of essential recombination-center elements and performed a coordinated side-by-side phenotypic analysis. Consistent with established heavy-chain-deficient models, Igh ablation caused a profound block in B-cell development beyond the pro-B stage, with marked loss of peripheral B cells and humoral effector populations. Consistent with classic Igκ -targeting studies, Igκ ablation permitted substantial B-cell development through compensatory Igλ usage. Within this matched experimental framework, Igκ -deficient mice also showed altered splenic and peritoneal B-cell subset composition, whereas Igh -deficient mice showed reduced splenic and thymic T-cell numbers, reduced Foxp3 + regulatory T-cell abundance, and altered secondary lymphoid-tissue organization. Together, the three mutant lines provide a comparative genetic resource and phenotypic reference for assessing the consequences of defined Igh and Igκ lesions across multiple immune compartments.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: